The dietary supplements industry will have the valuable opportunity to meet with member of Congress, especially new members, during the Natural Products Association’s (NPA; Washington, DC) 14th annual Natural Products Day on Wednesday, April 6.
The dietary supplements industry will have the valuable opportunity to meet with member of Congress, especially new members, during the Natural Products Association’s (NPA; Washington, DC) 14th annual Natural Products Day on Wednesday, April 6.
Attendees will visit congressional offices and talk to Senators, Representatives, and theirstaffs about key legislation that may impact the natural products industry, as well as to educate them about the important preventative role natural products play in keeping Americans healthy.
“Natural Products Day is a great way for industry members to get a foot in the doors of the policymakers who can make a difference. Nothing makes a greater impact on elected officials than a face-to-face meeting with a constituent,” said John Gay, NPA executive director and CEO. “Next year’s event will allow us to share our story with new members of Congress who probably do not fully understand our industry.”
“NPA and the natural products industry must reinforce our existing ties, and seek new allies to strengthen the industry’s position in Congress,” he added.
The event will begin with a morning session led by association and government relations experts talking about effective ways to communicate with legislators and providing updates on key legislation. An end-of-the-day reception will honor those legislators who have worked hard to support initiatives important to the industry.
For more information and updates, visit www.npainfo.org/NPD11.
DOJ asks Utah court to dismiss FTC lawsuit against Xlear Inc.
March 11th 2025On March 10, the DOJ and the defendant filed a stipulation to dismiss with prejudice the lawsuit in which each party agrees “to be responsible for its own costs and fees and agrees that no party shall be responsible to any other party for any fines, costs, fees, or penalties arising from this case.”
HHS announces efforts to eliminate independent conclusion of GRAS
Published: March 11th 2025 | Updated: March 11th 2025U.S. Department of Health and Human Services (HHS) Secretary, Robert F. Kennedy Jr., is directing the acting U.S. Food and Drug Administration’s (FDA) acting commissioner to explore rulemaking that would eliminate the independent conclusion of GRAS provision.